These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 20449589)
1. Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein. Kampmeier F; Niesen J; Koers A; Ribbert M; Brecht A; Fischer R; Kiessling F; Barth S; Thepen T Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1926-34. PubMed ID: 20449589 [TBL] [Abstract][Full Text] [Related]
2. The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F. Woitok M; Klose D; Niesen J; Richter W; Abbas M; Stein C; Fendel R; Bialon M; Püttmann C; Fischer R; Barth S; Kolberg K Cancer Lett; 2016 Oct; 381(2):323-30. PubMed ID: 27502168 [TBL] [Abstract][Full Text] [Related]
3. In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model. Pardo A; Stöcker M; Kampmeier F; Melmer G; Fischer R; Thepen T; Barth S Cancer Immunol Immunother; 2012 Oct; 61(10):1617-26. PubMed ID: 22350071 [TBL] [Abstract][Full Text] [Related]
4. Development of SNAP-tag fluorogenic probes for wash-free fluorescence imaging. Sun X; Zhang A; Baker B; Sun L; Howard A; Buswell J; Maurel D; Masharina A; Johnsson K; Noren CJ; Xu MQ; Corrêa IR Chembiochem; 2011 Sep; 12(14):2217-26. PubMed ID: 21793150 [TBL] [Abstract][Full Text] [Related]
6. Near infrared imaging of epidermal growth factor receptor positive xenografts in mice with domain I/II specific antibody fragments. Bernhard W; El-Sayed A; Barreto K; Gonzalez C; Fonge H; Geyer CR Theranostics; 2019; 9(4):974-985. PubMed ID: 30867810 [TBL] [Abstract][Full Text] [Related]
7. Zwitterionic near-infrared fluorophore-conjugated epidermal growth factor for fast, real-time, and target-cell-specific cancer imaging. Kim H; Cho MH; Choi HS; Lee BI; Choi Y Theranostics; 2019; 9(4):1085-1095. PubMed ID: 30867817 [TBL] [Abstract][Full Text] [Related]
9. Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount. Tolmachev V; Rosik D; Wållberg H; Sjöberg A; Sandström M; Hansson M; Wennborg A; Orlova A Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):613-22. PubMed ID: 19838701 [TBL] [Abstract][Full Text] [Related]
10. SNAP-Tag Technology: A Useful Tool To Determine Affinity Constants and Other Functional Parameters of Novel Antibody Fragments. Niesen J; Sack M; Seidel M; Fendel R; Barth S; Fischer R; Stein C Bioconjug Chem; 2016 Aug; 27(8):1931-41. PubMed ID: 27391930 [TBL] [Abstract][Full Text] [Related]
11. A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR. von Felbert V; Bauerschlag D; Maass N; Bräutigam K; Meinhold-Heerlein I; Woitok M; Barth S; Hussain AF J Cancer Res Clin Oncol; 2016 May; 142(5):1003-11. PubMed ID: 26847542 [TBL] [Abstract][Full Text] [Related]
12. EpCAM- and EGFR-Specific Antibody Drug Conjugates for Triple-Negative Breast Cancer Treatment. Zhang C; Sheng W; Al-Rawe M; Mohiuddin TM; Niebert M; Zeppernick F; Meihold-Heerlein I; Hussain AF Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682800 [TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore. Gong H; Kovar J; Little G; Chen H; Olive DM Neoplasia; 2010 Feb; 12(2):139-49. PubMed ID: 20126472 [TBL] [Abstract][Full Text] [Related]
14. SNAP-tag technology mediates site specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cells. Hussain AF; Kampmeier F; von Felbert V; Merk HF; Tur MK; Barth S Bioconjug Chem; 2011 Dec; 22(12):2487-95. PubMed ID: 21995499 [TBL] [Abstract][Full Text] [Related]
15. An Investigation into the In Vitro Targeted Killing of CD44-Expressing Triple-Negative Breast Cancer Cells Using Recombinant Photoimmunotherapeutics Compared to Auristatin-F-Based Antibody-Drug Conjugates. Mungra N; Nsole Biteghe FA; Huysamen AM; Hardcastle NS; Bunjun R; Naran K; Lang D; Richter W; Hunter R; Barth S Mol Pharm; 2024 Aug; 21(8):4098-4115. PubMed ID: 39047292 [TBL] [Abstract][Full Text] [Related]
16. Near-Infrared Fluorescence Imaging of EGFR-Overexpressing Tumors in the Mouse Xenograft Model Using scFv-IRDye800CW and Cetuximab-IRDye800CW. Amini A; Safdari Y; Tash Shamsabadi F Mol Imaging; 2022; 2022():9589820. PubMed ID: 35517713 [TBL] [Abstract][Full Text] [Related]
17. Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment. He J; Wang Y; Feng J; Zhu X; Lan X; Iyer AK; Zhang N; Seo Y; VanBrocklin HF; Liu B J Nucl Med; 2010 Mar; 51(3):427-32. PubMed ID: 20150269 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous inhibition of epidermal growth factor receptor (EGFR) signaling and enhanced activation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-mediated apoptosis induction by an scFv:sTRAIL fusion protein with specificity for human EGFR. Bremer E; Samplonius DF; van Genne L; Dijkstra MH; Kroesen BJ; de Leij LF; Helfrich W J Biol Chem; 2005 Mar; 280(11):10025-33. PubMed ID: 15644326 [TBL] [Abstract][Full Text] [Related]